Cardiovascular Summit 2025 - Heart Failure Highlights

The Past, Present and Future

Bayer's Cardiovascular Summit took place in London on the 3rd and 4th of October 2025.

Designed to offer education including expert perspectives and discussions on the management of Heart Failure, including differential diagnoses such as Cardiomyopathy and Amyloidosis, with a focus on Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Heart Failure (HF) Key Highlights

Here you can find short videos from our expert speakers, highlighting key points from the sessions discussing Heart Failure in depth, including;

What is Heart Failure with Preserved Ejection Fraction (HFpEF)?
Approaches to Patients with HFpEF

What is HFpEF?

Dr Kate Gatenby (5 Minutes)

HFpEF Approach

Dr Kate Gatenby (4 Minutes)

Please double click on the video to view it full screen.

Beyonttra

▼
(acoramidis) Prescribing Information
.

Kerendia▼(finerenone) Prescribing Information

^{This promotional meeting was initiated and funded by Bayer UK and is for UK Healthcare professionals only}

Find out more about our Expert Speakers

Dr Kate Gatenby - Consultant Cardiologist, Leeds General Infirmary

Dr Gatenby is a Consultant Cardiologist at the Leeds General Infirmary, subspecialising in heart failure, echocardiography and obstetric cardiology. She has a particular interest in managing patients with combined valvular heart disease and heart failure, the integrated management of heart failure across primary and secondary care, identification and management of patients with advanced heart failure.